London
· Delayed Price · Currency is GBP · Price in CHF Newron Pharmaceuticals Statistics
Total Valuation
LON:0QOI has a market cap or net worth of GBP 151.66 million. The enterprise value is 186.52 million.
| Market Cap | 151.66M |
| Enterprise Value | 186.52M |
Important Dates
The next estimated earnings date is Tuesday, September 16, 2025.
| Earnings Date | Sep 16, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +15.30% |
| Shares Change (QoQ) | +21.68% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 18.88M |
Valuation Ratios
The trailing PE ratio is 11.58.
| PE Ratio | 11.58 |
| Forward PE | n/a |
| PS Ratio | 3.57 |
| PB Ratio | 125.78 |
| P/TBV Ratio | 125.78 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.25, with an EV/FCF ratio of -12.80.
| EV / Earnings | 14.24 |
| EV / Sales | 4.23 |
| EV / EBITDA | 8.25 |
| EV / EBIT | 8.31 |
| EV / FCF | -12.80 |
Financial Position
The company has a current ratio of 2.60, with a Debt / Equity ratio of 34.62.
| Current Ratio | 2.60 |
| Quick Ratio | 2.42 |
| Debt / Equity | 34.62 |
| Debt / EBITDA | 1.91 |
| Debt / FCF | -2.86 |
| Interest Coverage | 6.01 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 36.44% |
| Return on Invested Capital (ROIC) | 46.45% |
| Return on Capital Employed (ROCE) | 64.78% |
| Revenue Per Employee | 1.93M |
| Profits Per Employee | 595,531 |
| Employee Count | 22 |
| Asset Turnover | 1.14 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -0.82% in the last 52 weeks. The beta is 0.94, so LON:0QOI's price volatility has been similar to the market average.
| Beta (5Y) | 0.94 |
| 52-Week Price Change | -0.82% |
| 50-Day Moving Average | 8.18 |
| 200-Day Moving Average | 7.94 |
| Relative Strength Index (RSI) | 62.61 |
| Average Volume (20 Days) | 1,439 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, LON:0QOI had revenue of GBP 42.50 million and earned 13.10 million in profits. Earnings per share was 0.64.
| Revenue | 42.50M |
| Gross Profit | 42.50M |
| Operating Income | 21.64M |
| Pretax Income | 17.69M |
| Net Income | 13.10M |
| EBITDA | 21.66M |
| EBIT | 21.64M |
| Earnings Per Share (EPS) | 0.64 |
Balance Sheet
The company has 8.13 million in cash and 41.74 million in debt, giving a net cash position of -33.61 million.
| Cash & Cash Equivalents | 8.13M |
| Total Debt | 41.74M |
| Net Cash | -33.61M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 1.21M |
| Book Value Per Share | 0.06 |
| Working Capital | 31.09M |
Cash Flow
In the last 12 months, operating cash flow was -14.57 million and capital expenditures -10,751, giving a free cash flow of -14.58 million.
| Operating Cash Flow | -14.57M |
| Capital Expenditures | -10,751 |
| Free Cash Flow | -14.58M |
| FCF Per Share | n/a |
Margins
Gross margin is 100.00%, with operating and profit margins of 50.93% and 30.83%.
| Gross Margin | 100.00% |
| Operating Margin | 50.93% |
| Pretax Margin | 41.63% |
| Profit Margin | 30.83% |
| EBITDA Margin | 50.98% |
| EBIT Margin | 50.93% |
| FCF Margin | n/a |
Dividends & Yields
LON:0QOI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -15.30% |
| Shareholder Yield | -15.30% |
| Earnings Yield | 8.64% |
| FCF Yield | -9.61% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
LON:0QOI has an Altman Z-Score of 4.65.
| Altman Z-Score | 4.65 |
| Piotroski F-Score | n/a |